We show our work.
This isn’t marketing copy. It’s the research, translated.
WHY FEMALE BIOLOGY MATTERS
Peptide research has a gender problem.
This matters because:
DOSING:
BPC-157 is dosed at 2.5-3.75 mcg/kg. A 60kg woman needs a meaningfully different dose than a 90kg man community protocols don't account for this. and most
TIMING:
GH secretion varies across the menstrual cycle. GHK-Cu's collagen-synthesis effect may be amplified during the follicular phase when estrogen is rising.
INTERACTIONS:
Tirzepatide reduces oral contraceptive absorption by up to 20%. Most peptide guides don't mention this.
SIDE EFFECTS:
GLP-1 side effects (nausea, Gl sensitivity) are frequently more pronounced during the luteal phase. Knowing this changes how you titrate.
(Each card links to a full compound deep-dive page)
GHK-Cu (Copper Peptide)
THE GLOW COLLECTION
Mechanism: Stimulates collagen synthesis, promotes angiogenesis, upregulates wound healing genes.
Female relevance: Collagen loss accelerates up to 30% in the first 5 years post-menopause. GHK-Cu directly addresses this pathway.
Evidence: 71-woman clinical study — daily topical application for 3 months significantly increased skin density and reduced sagging.
BPC-157
THE REPAIR COLLECTION / THE GLOW COLLECTION
Mechanism: Gastric-derived body protection compound. Promotes angiogenesis, tissue repair, and gut barrier integrity.
Female relevance: Non-hormonal. No virilization risk. Most commonly recommended first peptide for women.
Female dosing: Start at 200–250 mcg/day (lower than male-default community dosing).
Tirzepatide
Mechanism: Dual GIP/GLP-1 receptor agonist. Suppresses appetite, slows gastric emptying, improves insulin sensitivity.
Female relevance: Women consistently lose more weight on GLP-1 agonists than men in matched studies — likely due to hormonal interactions. 15.3% average weight loss at 12 months.
Key interaction: Reduces oral contraceptive bioavailability by up to 20%. Use barrier contraception for 4 weeks after each dose increase.
Epithalon
Mechanism: Synthetic tetrapeptide that activates telomerase — the enzyme responsible for maintaining telomere length.
Protocol: Standard “Ukrainian cycle” — 10mg daily for 20 days, 2x per year.
Female relevance: Telomere shortening accelerates post-menopause. Epithalon is among the most studied longevity peptides in Eastern European clinical research.
Selank
Mechanism: Tuftsin analog. Modulates GABA, serotonin, and dopamine pathways. Anxiolytic and nootropic effects.
Female relevance: Brain fog and anxiety are the most commonly reported cognitive symptoms of perimenopause. Selank addresses both pathways without the sedation profile of pharmaceutical anxiolytics.
Kisspeptin-10
Mechanism: Hypothalamic neuropeptide that triggers GnRH release and regulates the HPG (hypothalamic-pituitary-gonadal) axis.
Female relevance: Clinical data supports use in women with hypothalamic amenorrhea, PCOS, and hormonal dysregulation. One of the few peptides with meaningful human female trial data.